心血管指南

订阅

MedSci主页 / 所有栏目 / 心血管指南

2020 KSC/KATRD指南：肺动脉高压的诊断和治疗（概要）

2021-06-04 韩国心脏学会 Tuberc Respir Dis (Seoul)

高血压肺动脉高压

本文主要针对肺动脉高压的诊断和治疗提供指导建议。

中文标题：

2020 KSC/KATRD指南：肺动脉高压的诊断和治疗（概要）

英文标题：

2020 KSC/KATRD Guideline for the Diagnosis and Treatment of Pulmonary Hypertension: Executive Summary

发布机构：

韩国心脏学会

发布日期：

2021-06-04

简要介绍：

2021年6月，韩国心脏学会(KSC)联合韩国结核和呼吸疾病学会(KATRD)发布了肺动脉高压的诊断和治疗指南。肺动脉高压（PH）是一种非动脉血压升高的情况，诊断为平均肺动脉压升高≥25mmHg。可能与多种临床情况有关。本文主要针对肺动脉高压的诊断和治疗提供指导建议。

相关资料下载：
[AttachmentFileName(sort=1, fileName=2020 KSC／KATRD指南：肺动脉高压的诊断和治疗.pdf)] GetToolGuiderByIdResponse(projectId=1, id=c279d1c002265e4c, title=2020 KSC/KATRD指南：肺动脉高压的诊断和治疗（概要）, enTitle=2020 KSC/KATRD Guideline for the Diagnosis and Treatment of Pulmonary Hypertension: Executive Summary, guiderFrom=Tuberc Respir Dis (Seoul), authorId=0, author=, summary=本文主要针对肺动脉高压的诊断和治疗提供指导建议。, cover=https://img.medsci.cn/20211118/1637230375436_1608702.jpg, journalId=0, articlesId=null, associationId=1839, associationName=韩国心脏学会, associationIntro= , copyright=0, guiderPublishedTime=Fri Jun 04 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<p><span style="color: #373737;">2021年6月，韩国心脏学会(KSC)联合韩国结核和呼吸疾病学会(KATRD)发布了肺动脉高压的诊断和治疗指南。肺动脉高压（PH）是一种非动脉血压升高的情况，诊断为平均肺动脉压升高&ge;25mmHg。可能与多种临床情况有关。本文主要针对肺动脉高压的诊断和治疗提供指导建议。</span></p>, tagList=[TagDto(tagId=274, tagName=高血压), TagDto(tagId=1179, tagName=肺动脉高压)], categoryList=[CategoryDto(categoryId=2, categoryName=心血管, tenant=100), CategoryDto(categoryId=12, categoryName=呼吸, tenant=100), CategoryDto(categoryId=38, categoryName=急重症, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=1179, guiderKeyword=肺动脉高压, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=1, guiderRegion=5, opened=0, paymentType=, paymentAmount=2, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=4233, appHits=300, showAppHits=0, pcHits=776, showPcHits=3931, likes=1, shares=13, comments=6, approvalStatus=1, publishedTime=Thu Nov 18 18:25:36 CST 2021, publishedTimeString=2021-06-04, pcVisible=1, appVisible=1, editorId=1614372, editor=MedSciZeng, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=3, createdBy=null, createdName=dajiong, createdTime=Thu Nov 18 18:18:19 CST 2021, updatedBy=1614372, updatedName=MedSciZeng, updatedTime=Fri Jan 05 11:49:25 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=2020 KSC／KATRD指南：肺动脉高压的诊断和治疗.pdf)])
2020 KSC／KATRD指南：肺动脉高压的诊断和治疗.pdf
下载请点击：
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2103464, encodeId=56e7210346422, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=43718258358, createdName=ms3000002106324246, createdTime=Wed Nov 30 09:58:56 CST 2022, time=2022-11-30, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1235267, encodeId=bcb3123526e66, content=中文版？, beContent=null, objectType=guider, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=25ab8250801, createdName=o,星星, createdTime=Thu Jul 28 12:44:05 CST 2022, time=2022-07-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1080868, encodeId=83aa108086815, content=如果有中文版就好了！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a9725519497, createdName=ms4000001570900680, createdTime=Thu Dec 16 21:01:58 CST 2021, time=2021-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1072293, encodeId=a22410e22934b, content=值得参考, beContent=null, objectType=guider, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3d3b2210771, createdName=120d521dm50暂无昵称, createdTime=Sat Nov 20 18:07:20 CST 2021, time=2021-11-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1071533, encodeId=e68e10e1533f7, content=@👍, beContent=null, objectType=guider, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bdaa1472607, createdName=543957, createdTime=Thu Nov 18 20:19:31 CST 2021, time=2021-11-18, status=1, ipAttribution=)]
    2022-11-30 ms3000002106324246 来自四川省

    学习了

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=2103464, encodeId=56e7210346422, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=43718258358, createdName=ms3000002106324246, createdTime=Wed Nov 30 09:58:56 CST 2022, time=2022-11-30, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1235267, encodeId=bcb3123526e66, content=中文版？, beContent=null, objectType=guider, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=25ab8250801, createdName=o,星星, createdTime=Thu Jul 28 12:44:05 CST 2022, time=2022-07-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1080868, encodeId=83aa108086815, content=如果有中文版就好了！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a9725519497, createdName=ms4000001570900680, createdTime=Thu Dec 16 21:01:58 CST 2021, time=2021-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1072293, encodeId=a22410e22934b, content=值得参考, beContent=null, objectType=guider, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3d3b2210771, createdName=120d521dm50暂无昵称, createdTime=Sat Nov 20 18:07:20 CST 2021, time=2021-11-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1071533, encodeId=e68e10e1533f7, content=@👍, beContent=null, objectType=guider, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bdaa1472607, createdName=543957, createdTime=Thu Nov 18 20:19:31 CST 2021, time=2021-11-18, status=1, ipAttribution=)]
    2022-07-28 o,星星

    中文版？

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=2103464, encodeId=56e7210346422, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=43718258358, createdName=ms3000002106324246, createdTime=Wed Nov 30 09:58:56 CST 2022, time=2022-11-30, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1235267, encodeId=bcb3123526e66, content=中文版？, beContent=null, objectType=guider, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=25ab8250801, createdName=o,星星, createdTime=Thu Jul 28 12:44:05 CST 2022, time=2022-07-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1080868, encodeId=83aa108086815, content=如果有中文版就好了！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a9725519497, createdName=ms4000001570900680, createdTime=Thu Dec 16 21:01:58 CST 2021, time=2021-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1072293, encodeId=a22410e22934b, content=值得参考, beContent=null, objectType=guider, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3d3b2210771, createdName=120d521dm50暂无昵称, createdTime=Sat Nov 20 18:07:20 CST 2021, time=2021-11-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1071533, encodeId=e68e10e1533f7, content=@👍, beContent=null, objectType=guider, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bdaa1472607, createdName=543957, createdTime=Thu Nov 18 20:19:31 CST 2021, time=2021-11-18, status=1, ipAttribution=)]
    2021-12-16 ms4000001570900680

    如果有中文版就好了！

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=2103464, encodeId=56e7210346422, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=43718258358, createdName=ms3000002106324246, createdTime=Wed Nov 30 09:58:56 CST 2022, time=2022-11-30, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1235267, encodeId=bcb3123526e66, content=中文版？, beContent=null, objectType=guider, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=25ab8250801, createdName=o,星星, createdTime=Thu Jul 28 12:44:05 CST 2022, time=2022-07-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1080868, encodeId=83aa108086815, content=如果有中文版就好了！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a9725519497, createdName=ms4000001570900680, createdTime=Thu Dec 16 21:01:58 CST 2021, time=2021-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1072293, encodeId=a22410e22934b, content=值得参考, beContent=null, objectType=guider, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3d3b2210771, createdName=120d521dm50暂无昵称, createdTime=Sat Nov 20 18:07:20 CST 2021, time=2021-11-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1071533, encodeId=e68e10e1533f7, content=@👍, beContent=null, objectType=guider, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bdaa1472607, createdName=543957, createdTime=Thu Nov 18 20:19:31 CST 2021, time=2021-11-18, status=1, ipAttribution=)]
    2021-11-20 120d521dm50暂无昵称

    值得参考

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=2103464, encodeId=56e7210346422, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=43718258358, createdName=ms3000002106324246, createdTime=Wed Nov 30 09:58:56 CST 2022, time=2022-11-30, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1235267, encodeId=bcb3123526e66, content=中文版？, beContent=null, objectType=guider, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=25ab8250801, createdName=o,星星, createdTime=Thu Jul 28 12:44:05 CST 2022, time=2022-07-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1080868, encodeId=83aa108086815, content=如果有中文版就好了！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a9725519497, createdName=ms4000001570900680, createdTime=Thu Dec 16 21:01:58 CST 2021, time=2021-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1072293, encodeId=a22410e22934b, content=值得参考, beContent=null, objectType=guider, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3d3b2210771, createdName=120d521dm50暂无昵称, createdTime=Sat Nov 20 18:07:20 CST 2021, time=2021-11-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1071533, encodeId=e68e10e1533f7, content=@👍, beContent=null, objectType=guider, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bdaa1472607, createdName=543957, createdTime=Thu Nov 18 20:19:31 CST 2021, time=2021-11-18, status=1, ipAttribution=)]
    2021-11-18 543957

    @👍

    0

相关指南

复方利血平氨苯蝶啶片( O 号) 临床应用中国专家共识( 2021 版)

中国老年医学学会高血压分会 · 2021-09-28

2021 AHA科学声明：预防和治疗高血压的减重策略

美国心脏协会(AHA,American Heart Association) · 2021-09-20

高血压基层合理用药指南

中华医学会(CMA,Chinese Medical Association) · 2021-01-04

世界卫生组织（WHO）：2021年成人高血压药物治疗指南

世界卫生组织(WHO,The World Health Organization) · 2021-08-26

成年人精神压力相关高血压诊疗专家共识

中国医师协会心血管内科医师分会(CCCP,Chinese College of Cardiovascular Physicians) · 2021-08-10

2021 ESH意见书：高血压和射血分数保留的心力衰竭

欧洲高血压学会(ESH,European Society of Hypertension) · 2021-05-30

拓展阅读

2011AHA 大面积和次大面积肺栓塞、髂股深静脉血栓形成以及慢性血栓栓塞性肺动脉高压的治疗指南

美国心脏协会(AHA,American Heart Association) · 2011-04-21

先天性心脏病相关肺动脉高压中国专家共识

中华医学会心血管病学分会(Chinese Society of Cardiology) · 2012-12-01

2013先天性心脏病相关性肺动脉高压诊治专家共识

中国心血管病相关专家小组（统称） · 2013-05-16

2014 肺动脉高压治疗流程

中国呼吸科专家组（统称） · 2014-01-02

2014 ATS临床实践指南：美国镰状细胞贫血患者肺动脉高压的诊断危险分层和管理

美国胸科学会(ATS,American Thoracic Society) · 2014-03-15

2014 ACCP成人肺动脉高压药物治疗指南

美国胸科医师学会(ACCP,American College of Chest Physicians) · 2014-06-17